| |
| |
|
| Insider
Information: |
Gorman Kevin Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
517,112 |
|
|
Indirect Shares
|
57,996 |
|
|
| Direct
Value |
$70,111,257 |
|
|
|
Indirect Value
|
$7,928,053 |
|
|
| Total
Shares |
575,108 |
|
|
| Total
Value |
$78,039,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 23.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XNCR |
Xencor Inc |
Director |
• • – |
2023-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,007 |
5,007 |
0 |
- |
|
| XNCR |
Xencor Inc |
Director |
• • – |
2024-02-13 |
4 |
B |
$19.12 |
$1,013 |
D/D |
53 |
5,060 |
2.31 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2016-12-23 |
4 |
OE |
$2.59 |
$23,569 |
D/D |
9,100 |
237,177 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2010-01-12 |
4 |
AS |
$2.52 |
$23,828 |
D/D |
(9,445) |
120,877 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-07 |
4 |
OE |
$8.66 |
$23,893 |
D/D |
2,759 |
420,356 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President & CEO |
• • – |
2009-01-13 |
4 |
AS |
$3.37 |
$31,014 |
D/D |
(9,195) |
82,802 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2010-03-01 |
4 |
AS |
$2.53 |
$39,491 |
D/D |
(15,609) |
146,935 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President & CEO |
• – – |
2008-02-12 |
4 |
AS |
$4.96 |
$41,369 |
D/D |
(8,230) |
66,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2009-03-30 |
4 |
AS |
$3.43 |
$51,927 |
D/D |
(15,146) |
109,322 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-05-02 |
4 |
OE |
$2.59 |
$56,304 |
D/D |
21,739 |
354,346 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2015-01-08 |
4 |
OE |
$2.59 |
$64,750 |
D/D |
25,000 |
205,952 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2014-01-10 |
4 |
AS |
$18.57 |
$69,638 |
D/D |
(3,750) |
180,952 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2003-05-22 |
4 |
A |
$48.51 |
$97,020 |
D/D |
2,000 |
29,497 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-09 |
4 |
OE |
$32.99 |
$99,993 |
D/D |
3,031 |
420,628 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-09-22 |
4 |
A |
$55.19 |
$100,059 |
D/D |
1,813 |
57,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-09-22 |
4 |
D |
$55.19 |
$100,059 |
I/I |
(1,813) |
57,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2015-03-24 |
4 |
OE |
$2.59 |
$103,600 |
D/D |
40,000 |
228,452 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2011-02-28 |
4 |
AS |
$6.83 |
$105,134 |
D/D |
(15,400) |
177,202 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2015-01-12 |
4 |
AS |
$28.43 |
$106,613 |
D/D |
(3,750) |
184,702 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-03-01 |
4 |
A |
$55.15 |
$110,300 |
D/D |
2,000 |
57,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2015-01-16 |
4 |
AS |
$30.79 |
$115,463 |
D/D |
(3,750) |
188,452 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2016-02-03 |
4 |
AS |
$38.04 |
$118,875 |
D/D |
(3,125) |
228,077 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-02-06 |
4 |
AS |
$43.18 |
$129,972 |
D/D |
(3,010) |
250,542 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-02-03 |
4 |
AS |
$42.55 |
$132,969 |
D/D |
(3,125) |
247,802 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-01-17 |
4 |
AS |
$40.65 |
$152,438 |
D/D |
(3,750) |
244,677 |
0 |
- |
|
82 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
